» Articles » PMID: 36187821

Cannabinoid Receptors in the Inflammatory Cells of Canine Atopic Dermatitis

Abstract

Background: Atopic dermatitis (AD) is one of the most common cutaneous inflammatory and pruritic diseases in dogs. Considering its multifactorial nature, AD can be a challenging disease to manage, and the therapeutic strategy must often be multimodal. In recent years, research has been moving toward the use of natural products which have beneficial effects on inflammation and itching, and no side effects. Cannabinoid receptors have been demonstrated to be expressed in healthy and diseased skin; therefore, one of the potential alternative therapeutic targets for investigating AD is the endocannabinoid system (ECS).

Objective: To immunohistochemically investigate the expression of the cannabinoid receptor type 2 (CB2R), and the cannabinoid-related receptors G protein-coupled receptor 55 (GPR55), transient receptor potential vanilloid 1 (TRPV1) and ankyrin 1 (TRPA1) in mast cells (MCs), macrophages, dendritic cells (DCs), T cells, and neutrophils of the skin of dogs with AD.

Animals: Samples of skin tissues were collected from eight dogs with AD (AD-dogs).

Materials And Methods: The immunofluorescent stained cryosections of the skins of 8 dogs with AD having antibodies against CB2R, GPR55, TRPV1, TRPA1 were semiquantitatively evaluated. The inflammatory cells were identified using antibodies against tryptase (mast cells), ionized calcium binding adaptor molecule 1 (IBA1) (macrophages/DCs), CD3 (T cells), and calprotectin (neutrophils). The proportions of MCs, macrophages/DCs, cells, and neutrophils expressing CB2R, GPR55, TRPV1 and TRPA1 were evaluated.

Results: The cells of the inflammatory infiltrate showed immunoreactivity (IR) for all or for some of the cannabinoid and cannabinoid-related receptors studied. In particular, MCs and macrophages/DCs showed CB2R-, GPR55-, TRPA1-, and TRPV1-IR; T cells showed CB2R-, GPR55- and TRPA1-IR, and neutrophils expressed GPR55-IR. Co-localization studies indicated that CB2R-IR was co-expressed with TRPV1-, TRPA1-, and GPR55-IR in different cellular elements of the dermis of the AD-dogs.

Conclusions And Clinical Importance: Cannabinoid receptor 2, and cannabinoid-related receptors GPR55, TRPV1 and TRPA1 were widely expressed in the inflammatory infiltrate of the AD-dogs. Based on the present findings, the ECS could be considered to be a potential therapeutic target for dogs with AD, and may mitigate itch and inflammation.

Citing Articles

CBD for pets: navigating quality assurance, safety standards, and marketing strategies.

Rideout H, Cook A, Whetton A J Cannabis Res. 2025; 7(1):6.

PMID: 39849662 PMC: 11755934. DOI: 10.1186/s42238-024-00257-5.


The Expression of Cannabinoid and Cannabinoid-Related Receptors on the Gustatory Cells of the Piglet Tongue.

Zamith Cunha R, Grilli E, Piva A, Delprete C, Franciosi C, Caprini M Molecules. 2024; 29(19).

PMID: 39407543 PMC: 11478043. DOI: 10.3390/molecules29194613.


Endocannabinoid system and phytocannabinoids in the main species of veterinary interest: a comparative review.

Di Salvo A, Chiaradia E, Sforna M, Rocca G Vet Res Commun. 2024; 48(5):2915-2941.

PMID: 39162768 PMC: 11442603. DOI: 10.1007/s11259-024-10509-7.


Dermatological evaluation in dogs with atopic dermatitis treated with full-spectrum high cannabidiol oil: a pre study part 1.

Mariga C, Souza Silva Mateus A, Dos Santos Dullius A, da Silva A, Flores M, Vasconcelos Soares A Front Vet Sci. 2023; 10:1285384.

PMID: 38026679 PMC: 10644039. DOI: 10.3389/fvets.2023.1285384.


Pharmacokinetics, efficacy, and safety of cannabidiol in dogs: an update of current knowledge.

Di Salvo A, Conti M, Rocca G Front Vet Sci. 2023; 10:1204526.

PMID: 37456953 PMC: 10347378. DOI: 10.3389/fvets.2023.1204526.

References
1.
Morales P, Hurst D, Reggio P . Molecular Targets of the Phytocannabinoids: A Complex Picture. Prog Chem Org Nat Prod. 2017; 103:103-131. PMC: 5345356. DOI: 10.1007/978-3-319-45541-9_4. View

2.
Nakashima C, Otsuka A, Kabashima K . Interleukin-31 and interleukin-31 receptor: New therapeutic targets for atopic dermatitis. Exp Dermatol. 2018; 27(4):327-331. DOI: 10.1111/exd.13533. View

3.
Cerrato S, Brazis P, Della Valle M, Miolo A, Puigdemont A . Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNFalpha release from canine skin mast cells. Vet Immunol Immunopathol. 2009; 133(1):9-15. DOI: 10.1016/j.vetimm.2009.06.011. View

4.
Kasraie S, Niebuhr M, Werfel T . Interleukin (IL)-31 activates signal transducer and activator of transcription (STAT)-1, STAT-5 and extracellular signal-regulated kinase 1/2 and down-regulates IL-12p40 production in activated human macrophages. Allergy. 2013; 68(6):739-47. DOI: 10.1111/all.12152. View

5.
He S, Peng Q, Walls A . Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: selective enhancement of eosinophil recruitment by histamine. J Immunol. 1998; 159(12):6216-25. View